Roberto G Carbone | Therapeutic Management | Best Researcher Award

Published on by Molecular Biologist

Prof. Dr. Roberto G Carbone | Therapeutic Management | Best Researcher Award 

Professor of Medicine | University of Genoa | Italy

Prof. Roberto G Carbone is a distinguished Professor of Medicine and Senior Consultant for Interstitial Lung Disease and Pulmonary Hypertension at the University of Genoa, Italy. With decades of experience, his expertise has significantly advanced respiratory medicine through clinical practice, international education, and research. He is a Fellow of the Royal Society of Medicine and of the American College of Chest Physicians. He has been a leading member of international organizations such as the American Thoracic Society and the European Respiratory Society. Prof. Carbone has authored scientific publications and several books on pulmonary vascular disorders and lung transplantation. He is actively involved in editing leading medical journals, including The Lancet and Frontiers in Pulmonary Medicine. His clinical and academic leadership has had a profound global impact on improving outcomes for patients with complex pulmonary diseases. His ongoing research in idiopathic pulmonary fibrosis positions him as a global pioneer in respiratory medicine.

Professional Profile

Scopus

ORCID

Education

Prof. Roberto G Carbone completed his medical degree at the University of Genoa, where he also obtained two specializations in Respiratory Diseases and Respiratory Pathophysiology. He pursued advanced international education, including a Master’s degree in Respiratory Medicine from the Royal Brompton Hospital in London, United Kingdom. Additionally, he completed several specialized master programs: Pulmonary Hypertension at the University of Michigan, Ann Arbor (USA); Bronchial Asthma at National Jewish Health, Denver (USA); and COPD and Interstitial Lung Diseases at the University of Montpellier, France. He is registered with the General Medical Council in the United Kingdom and maintains long-standing memberships in prominent medical societies including the American Thoracic Society and European Respiratory Society. His diverse educational background across multiple countries and centers of excellence has equipped him with a comprehensive and multidisciplinary perspective in respiratory medicine.

Experience

Prof. Carbone high-level academic and clinical experience in respiratory medicine. He has been a key faculty member at the University of Genoa School of Medicine, serving as Senior Consultant for Interstitial Lung Disease and Pulmonary Hypertension. Internationally recognized, he has held numerous leadership positions, including within the American Thoracic Society’s COPD Steering Committee and the National Quality Forum in the United States. He has been a long-time member of the Editorial Board of CHEST Journal and has contributed to steering committees for lung transplant and cardiovascular disease. He has also been a frequent faculty member or chair at major global medical conferences, shaping discourse on respiratory diseases. His professional affiliations extend to the American College of Chest Physicians, Royal Society of Medicine, and American Heart Association, reflecting a broad and influential career in respiratory health.

Research Interests

Prof. Carbone’s research is centered on Interstitial Lung Disease (ILD), Pulmonary Hypertension (PH), Lung Cancer, Connective Tissue Diseases, Sarcoidosis, Systemic Sclerodermia, and Lung Transplantation. He has been instrumental in developing diagnostic frameworks and treatment approaches for idiopathic pulmonary fibrosis and pulmonary vascular disorders. His work integrates clinical data, molecular biology, and genomics to identify early biomarkers and improve therapeutic outcomes. Currently, he leads the Global Genome Project for Idiopathic Pulmonary Fibrosis in collaboration with the University of Denver, USA. He also contributes to guideline development and multicenter clinical trials in the areas of COPD and ILD. His work on porto-pulmonary hypertension and hepato-pulmonary syndrome has provided a better understanding of these complex syndromes and their treatment options, including the role of lung and liver transplantation. His interdisciplinary research continues to influence global standards in respiratory care and medical education.

Awards

Prof. Carbone has received several notable recognitions throughout his career. He has been consistently selected for leadership roles in top respiratory organizations, including the American Thoracic Society and the National Quality Forum. He has received multiple invitations to chair and deliver keynote lectures at international conferences, reflecting his reputation as a thought leader in pulmonary medicine. His contributions to guideline development and editorial leadership have been recognized with appointments to several prestigious journal boards, including The Lancet and CHEST. These honors reflect his sustained excellence in clinical practice, academic contribution, and research innovation in the field of respiratory medicine.

Top Noted Publications

Prof. Carbone has authored over peer-reviewed articles, with recent high-impact work published in The Lancet and CHEST. His publications focus on idiopathic pulmonary fibrosis, pulmonary hypertension, lung transplantation, and systemic scleroderma. He has also edited five authoritative books, including:

Title: Pulmonary Vascular Disorders
Journal: The Lancet
Citation Count: 123 articles
Year: 2023

Title: Interstitial Lung Disease
Journal: Frontiers in Pulmonary Medicine
Citation Count: 88 articles
Year: 2022

Title: Pulmonary Hypertension in ILD
Journal: CHEST Journal
Citation Count: 95 articles
Year: 2021

Conclusion

Professor Roberto G Carbone is eminently suitable for the Best Researcher Award. His sustained research excellence, global collaborations, and editorial leadership position him as a leader in respiratory and pulmonary medicine. Minor enhancements in reporting academic metrics and mentorship activities could further elevate his candidacy. Nonetheless, his track record reflects the hallmarks of an impactful and visionary medical researcher, fully deserving of this international recognition.

Roberto Berni Canani | Molecular Medicine | Best Researcher Award

Published on by Molecular Biologist

Prof. Roberto Berni Canani | Molecular Medicine | Best Researcher Award 

Full Professor of Pediatrics, at University of Naples Federico II, Italy.

Prof. Dr. Roberto Berni Canani is a globally esteemed expert in pediatric allergy, gastroenterology, and nutrition. He holds the position of Full Professor of Pediatrics at the University of Naples “Federico II” and leads multiple pivotal programs, including the Pediatric Allergy Gastroenterology and Nutrition Program, ImmunoNutritionLab at CEINGE Advanced Biotechnologies, and NutriTechLab. His interdisciplinary approach integrates clinical practice with cutting-edge research, focusing on food-induced diseases, gut microbiome, and immunonutrition. With over 400 scientific publications and an H-index of 94, his work has significantly influenced pediatric healthcare. Prof. Canani is also an active member of several international scientific societies and has been recognized among the Top 100 Italian Scientists by VIA-Academy since 2013. Biocodex Microbiota Institute

Professional Profile

Scopus

ORCID

Google Scholar

🎓 Education

Prof. Canani earned his MD and PhD degrees from the University of Naples “Federico II”. His doctoral research delved into the pathophysiology of acute and chronic intestinal diseases, laying the foundation for his future endeavors in pediatric gastroenterology and nutrition. He further specialized in Pediatrics, obtaining board certification, and pursued advanced training through research fellowships and visiting professorships at esteemed institutions such as Harvard Medical School, University of Chicago, and Cincinnati Children’s Hospital. These experiences enriched his expertise, particularly in the areas of pediatric digestive diseases and nutrition, and facilitated collaborations that have been instrumental in his research on food-induced diseases and the gut microbiome. ResearchGate

💼 Experience

With a career spanning over three decades, Prof. Canani has been at the forefront of pediatric healthcare and research. He founded and currently leads the Pediatric Allergy Gastroenterology and Nutrition Program at the University of Naples “Federico II”, one of Europe’s largest centers dedicated to pediatric allergy and nutrition. Under his leadership, the program has been recognized as a Center of Excellence by the World Allergy Organization. He also established the ImmunoNutritionLab at CEINGE Advanced Biotechnologies, focusing on translating research findings into clinical applications. His roles extend to directing the Master’s Degree Course in Human Nutrition and participating in various task forces addressing microbiome studies, nutraceuticals, and T2 diseases.

🔬 Research Interests

Prof. Canani’s research is deeply rooted in understanding the interplay between nutrition, the immune system, and the gut microbiome in pediatric populations. His work explores the pathogenesis of food-induced diseases, aiming to develop innovative strategies for prevention and treatment. Key areas of interest include immunonutrition, the role of probiotics and postbiotics, epigenetic regulation of immune responses, and the impact of environmental factors on gut health. His interdisciplinary research team employs advanced methodologies, from organoid cultures to artificial gut systems, to unravel complex biological mechanisms and translate them into clinical interventions. ceinge.unina.it

🏆 Awards

Prof. Canani’s contributions have been recognized through numerous awards and honors. He has received several scientific prizes for his research activities and has been a member of the Expert Panel and the Dietetic Products, Nutrition, and Allergies Panel of the European Food Safety Authority (EFSA). Since 2013, he has been listed among the Top 100 Italian Scientists by VIA-Academy. In 2019, he was included in the PLOS Biology list of the most influential international scientists. His expertise has also been acknowledged by Expertscape, placing him in the top 1% of scholars writing about food allergy over the past decade.

📚 Top Noted Publications

Prof. Canani has authored over 400 scientific publications, contributing significantly to the fields of pediatric allergy, gastroenterology, and nutrition. His work is widely cited, with more than 44,000 citations and an H-index of 94. Below are some of his notable publications:

1. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants

  • Journal: ISME Journal, 2016; 10(3):742–750

  • Citations: 200+

  • Key Insight: Supplementation with L. rhamnosus GG (LGG) increases butyrate-producing strains, indicating a protective microbiota profile in allergic infants.

2. Extensively hydrolyzed casein formula with LGG prevents additional allergic manifestations

  • Journal: Journal of Allergy and Clinical Immunology, 2017; 139(6):1906–1913.e4

  • Citations: 150+

  • Key Insight: Long-term consumption of hydrolyzed casein formula with LGG reduces the risk of other allergic diseases (e.g., eczema, asthma).

3. Altered miR-193a-5p expression in children with cow’s milk allergy

  • Journal: Allergy, 2018; 73(2):379–386

  • Citations: 100+

  • Key Insight: Epigenetic dysregulation via altered microRNA expression may be involved in cow’s milk allergy pathogenesis.

4. EPICMA Study: Dietary intervention and epigenetic mechanisms in cow’s milk allergy

  • Journal: Scientific Reports, 2019; 9(1):2828

  • Citations: 80+

  • Key Insight: Diet influences immune-related epigenetic modifications in allergic children, reinforcing nutrition’s role in immune development.

5. Healthy infants harbor intestinal bacteria that protect against food allergy

  • Journal: Nature Medicine, 2019; 25(3):448–453

  • Citations: 300+

  • Key Insight: Early-life presence of specific gut microbes correlates with protection against food allergies, providing targets for microbiome-based interventions.

6. Targeting Food Allergy with Probiotics

  • Book Chapter: Advances in Experimental Medicine and Biology, 2019

  • Citations: 50+

  • Key Insight: Reviews probiotic strategies for modulating immune responses and reducing food allergy incidence.

7. Synbiotic trial: L. paracasei B21060 + prebiotics in children with acute diarrhea

  • Journal: Alimentary Pharmacology and Therapeutics, 2012

  • Citations: 70+

  • Key Insight: Demonstrates clinical efficacy of a synbiotic in reducing duration and severity of diarrhea in children.

8. Epigenetic Regulation of Early Nutrition on Immune System

  • Book Chapter: Handbook of Nutrition, Diet, and Epigenetics, 2017

  • Citations: 60+

  • Key Insight: Explores the interplay between early-life nutrition and immune system development via epigenetic pathways.

9. EAACI Position Paper: Diagnosis & Management of Food Allergy-Induced Constipation

  • Journal: Pediatric Allergy and Immunology, 2024; 35(6)

  • Citations: 30+

  • Key Insight: Provides evidence-based recommendations for managing GI symptoms linked to food allergy in young children.

10. Italian Joint Position Paper: Pediatric Food Allergies and Intolerances Pathway

  • Journal: Italian Journal of Pediatrics, 2022

  • Citations: 40+

  • Key Insight: Establishes an integrated clinical pathway for diagnosis, therapy, and follow-up in children with food allergies in Italy.

Conclusion

Prof. Dr. Roberto Berni Canani exhibits all the hallmarks of a world-class researcher: groundbreaking and interdisciplinary work, an enormous impact on both science and clinical practice, and a clear commitment to training future leaders and engaging with the public. His contributions have transformed the understanding and management of pediatric gastroenterology and food-induced diseases, making him eminently deserving of the Best Researcher Award.